Clinical Trials Browser

Phase NA × pembrolizumab × Genitourinary × Clear all

NCT07629700 2026-06-05

ENDEAVOR

Phase NA Not yet recruiting

Carcinoma, Transitional Cell, Peripheral Nervous System Diseases

NCT02489357 2021-11-12

Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer

Phase NA Completed

12 enrolled 5 charts

Prostatic Neoplasms